Skip to main content

Table 1 Study procedures

From: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries

STUDY PROCEDURES

VISIT 1

VISIT 2

Informed consent

X

 

Inclusion/exclusion criteria

X

 

Medical/surgical history

X

X

Vital signs

X

X

Physical examination

X

X

Concomitant medication

X

X

Alcohol consumption questionnaire (AUDIT)

X

X

Quality of life questionnaires (EuroQoL 5d-3)

X

 

Health survey (SF-12)

X

 

LABORATORY ASSESSMENTS

 HCV/HBV serologies

X

 

 ALT/AST levels

X

X

 GGT/AP levels

X

X

 Haematology

X

 

 Biochemistry

X

 

 Coagulation

X

 

 Leucocyte and CRP

X

 

 Antibodies for autoimmune and celiac diseases

 

X

 Biochemistry: TSH, ceruloplasmin, α1AT, bilirubin

 

X

BIOBANK

 Blood samples: plasma, serum, DNA.

X

 

VC TRANSIENT ELASTOGRAPHY

X

X

ABDOMINAL ULTRASOUND

 

X

LIVER BIOPSY

 

X

AE assessment

X

X

  1. AE adverse event, AP alkaline phosphatase, α1AT α1-antitrypsin, CRP C-reactive protein, HBV hepatitis B virus, HCV hepatitis C virus, TSH thyroid stimulating hormone